Literature DB >> 26948709

Atrial flutter in myotonic dystrophy type 1: Patient characteristics and clinical outcome.

Karim Wahbi1, Frederic A Sebag2, Nicolas Lellouche2, Arnaud Lazarus3, Henri-Marc Bécane4, Guillaume Bassez5, Tanya Stojkovic4, Abdallah Fayssoil4, Pascal Laforêt4, Anthony Béhin4, Christophe Meune6, Bruno Eymard4, Denis Duboc7.   

Abstract

The prevalence and the incidence of atrial flutter in patients with myotonic dystrophy type 1 (DM1) and the most appropriate strategies for its management are unknown. We retrospectively included in the DM1 Heart Registry 929 adult patients with DM1 admitted to our Institutions between January 2000 and September 2013. We selected patients presenting with atrial flutter and analysed data relative to the occurrence of arterial thromboembolism, severe bradyarrhythmias and atrial flutter recurrences. Atrial flutter was present in 79 of the 929 patients included in our Registry, representing a 8.5% prevalence. Patients with atrial flutter were older, had a higher muscular disability rating scale score and had higher prevalence of other cardiac manifestations of DM1. Sixty patients presented with a first episode of atrial flutter, representing a 4.6% incidence. Severe bradyarrhythmias requiring permanent pacing were present in 4 patients (6.7%). Over a 53 ± 28 months mean follow-up duration, 2 patients (3.3%) had ischaemic stroke and 12 (20%) had atrial flutter recurrences. Patients who underwent radiofrequency ablation were more frequently free of atrial flutter recurrence than other patients (95 vs. 61%; HR = 0.17; P = 0.04). Atrial flutter is a common manifestation of DM1, potentially complicated by arterial thromboembolism or severe bradyarrhythmias. Radiofrequency catheter ablation is associated with a lower risk for recurrences.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrial flutter; Myotonic dystrophy type 1; Radiofrequency ablation; Supraventricular arrhythmia

Mesh:

Year:  2016        PMID: 26948709     DOI: 10.1016/j.nmd.2016.01.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  3 in total

1.  A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre.

Authors:  Elisabetta Bucci; Marco Testa; Loretta Licchelli; Alessandra Frattari; Nadia Attalla El Halabieh; Erica Gabriele; Giulia Pignatelli; Tiziana De Santis; Laura Fionda; Fiammetta Vanoli; Stefania Morino; Matteo Garibaldi; Antonella Di Pasquale; Nicola Vanacore; Annalisa Botta; Giovanni Antonini
Journal:  J Neurol       Date:  2018-02-10       Impact factor: 4.849

2.  Cardiac Involvement and Arrhythmias Associated with Myotonic Dystrophy.

Authors:  Daniel McBride; Amrish Deshmukh; Supriya Shore; Melissa A Elafros; Jackson J Liang
Journal:  Rev Cardiovasc Med       Date:  2022-04-02       Impact factor: 4.430

Review 3.  Clinical Care Recommendations for Cardiologists Treating Adults With Myotonic Dystrophy.

Authors:  Elizabeth M McNally; Douglas L Mann; Yigal Pinto; Deepak Bhakta; Gordon Tomaselli; Saman Nazarian; William J Groh; Takuhisa Tamura; Denis Duboc; Hideki Itoh; Leah Hellerstein; Pradeep P A Mammen
Journal:  J Am Heart Assoc       Date:  2020-02-06       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.